Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy.

Weiss GJ, Beck J, Braun DP, Bornemann-Kolatzki K, Barilla H, Cubello R, Quan W Jr, Sangal A, Khemka V, Waypa J, Mitchell WM, Urnovitz H, Sch├╝tz E.

Clin Cancer Res. 2017 Sep 1;23(17):5074-5081. doi: 10.1158/1078-0432.CCR-17-0231. Epub 2017 Mar 20.

PMID:
28320758
2.

Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation.

Ali I, Medegan B, Braun DP.

Int J Mol Sci. 2016 Apr 2;17(4):495. doi: 10.3390/ijms17040495.

3.

Fatigue as a Driver of Overall Quality of Life in Cancer Patients.

McCabe RM, Grutsch JF, Braun DP, Nutakki SB.

PLoS One. 2015 Jun 12;10(6):e0130023. doi: 10.1371/journal.pone.0130023. eCollection 2015.

5.

Can quality of life assessments differentiate heterogeneous cancer patients?

McCabe RM, Grutsch JF, Nutakki SB, Braun DP, Markman M.

PLoS One. 2014 Jun 11;9(6):e99445. doi: 10.1371/journal.pone.0099445. eCollection 2014.

6.

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.

Vashi PG, Gupta D, Lammersfeld CA, Braun DP, Popiel B, Misra S, Brown KC.

Nutr J. 2013 Aug 14;12:118. doi: 10.1186/1475-2891-12-118.

7.

Prognostic value of changes in quality of life scores in prostate cancer.

Gupta D, Braun DP, Staren ED.

BMC Urol. 2013 Jul 10;13:32. doi: 10.1186/1471-2490-13-32.

8.

Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer.

Gupta D, Braun DP, Staren ED, Markman M.

J Ovarian Res. 2013 Mar 8;6(1):17. doi: 10.1186/1757-2215-6-17.

9.

Effect of naturopathic and nutritional supplement treatment on tumor response, control, and recurrence in patients with prostate cancer treated with radiation therapy.

Braun DP, Gupta D, Birdsall TC, Sumner M, Staren ED.

J Altern Complement Med. 2013 Mar;19(3):198-203. doi: 10.1089/acm.2011.0657. Epub 2012 Oct 4.

10.

Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer.

Braun DP, Gupta D, Staren ED.

Pancreas. 2013 Mar;42(2):254-9. doi: 10.1097/MPA.0b013e31825b9f56.

PMID:
22850626
11.

Association between changes in quality of life scores and survival in non-small cell lung cancer patients.

Gupta D, Braun DP, Staren ED.

Eur J Cancer Care (Engl). 2012 Sep;21(5):614-22. doi: 10.1111/j.1365-2354.2012.01332.x. Epub 2012 Feb 6.

PMID:
22309434
12.

Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature.

Gupta D, Vashi PG, Lammersfeld CA, Braun DP.

Ann Nutr Metab. 2011;59(2-4):96-106. doi: 10.1159/000332914. Epub 2011 Dec 2. Review.

13.

The prognostic role of quality of life assessment in breast cancer.

Staren ED, Gupta D, Braun DP.

Breast J. 2011 Nov-Dec;17(6):571-8. doi: 10.1111/j.1524-4741.2011.01151.x. Epub 2011 Sep 4.

PMID:
21895846
14.

Quality of life assessment as a predictor of survival in non-small cell lung cancer.

Braun DP, Gupta D, Staren ED.

BMC Cancer. 2011 Aug 15;11:353. doi: 10.1186/1471-2407-11-353.

15.

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

Braun DP, Gupta D, Grutsch JF, Staren ED.

Health Qual Life Outcomes. 2011 Aug 3;9:62. doi: 10.1186/1477-7525-9-62.

16.

Predicting survival in prostate cancer: the role of quality of life assessment.

Braun DP, Gupta D, Staren ED.

Support Care Cancer. 2012 Jun;20(6):1267-74. doi: 10.1007/s00520-011-1213-x. Epub 2011 Jun 28.

17.

The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer.

Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DF, Reynolds JL, Ansell CM, Oh EY, Daehler MA, Levin RD, Braun DP, Gupta D, Lis CG, Hrushesky WJ.

BMC Cancer. 2011 May 23;11:193. doi: 10.1186/1471-2407-11-193.

18.

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.

Vashi PG, Lammersfeld CA, Braun DP, Gupta D.

Nutr J. 2011 May 16;10:51. doi: 10.1186/1475-2891-10-51.

19.

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.

Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D.

Nutr J. 2010 Nov 23;9:60. doi: 10.1186/1475-2891-9-60.

20.

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer.

Gupta D, Lammersfeld CA, Vashi PG, Braun DP.

J Ovarian Res. 2010 Oct 12;3:22. doi: 10.1186/1757-2215-3-22.

21.

Optimizing innovation in health care organizations.

Staren ED, Braun DP, Denny DS.

Physician Exec. 2010 Mar-Apr;36(2):54-8, 60-2.

PMID:
20411849
22.

Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosis.

Braun DP, Ding J, Shaheen F, Willey JC, Rana N, Dmowski WP.

Fertil Steril. 2007 Feb;87(2):263-8. Epub 2006 Nov 13.

PMID:
17094974
23.

Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity.

Braun DP, Crist KA, Shaheen F, Staren ED, Andrews S, Parker J.

Am J Surg. 2005 Oct;190(4):570-1.

PMID:
16164922
24.

Immunology of endometriosis.

Paul Dmowski W, Braun DP.

Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):245-63. Review.

PMID:
15157641
25.

Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis.

Braun DP, Ding J, Shen J, Rana N, Fernandez BB, Dmowski WP.

Fertil Steril. 2002 Oct;78(4):830-5.

PMID:
12372464
27.

Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer.

Ortegel JW, Staren ED, Faber LP, Warren WH, Braun DP.

Lung Cancer. 2002 Apr;36(1):17-25.

PMID:
11891029
28.

Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis.

Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP.

Hum Reprod. 2001 Sep;16(9):1802-8.

PMID:
11527879
29.
30.

Virulizin(R) - A review of its antineoplastic activity.

Ferdinandi ES, Braun DP, Liu C, Zee BC, Ely G.

Expert Opin Investig Drugs. 1999 Oct;8(10):1721-1735.

PMID:
11139822
31.

Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma.

Ortegel JW, Staren ED, Faber LP, Warren WH, Braun DP.

Cancer Immunol Immunother. 2000 Feb;48(11):627-34.

PMID:
10663610
32.

Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis.

Dmowski WP, Gebel H, Braun DP.

Hum Reprod Update. 1998 Sep-Oct;4(5):696-701.

PMID:
10027622
33.

Endometriosis: abnormal endometrium and dysfunctional immune response.

Braun DP, Dmowski WP.

Curr Opin Obstet Gynecol. 1998 Oct;10(5):365-9. Review.

PMID:
9818213
34.

Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.

Wong PY, Staren ED, Tereshkova N, Braun DP.

J Surg Res. 1998 Apr;76(1):95-103.

PMID:
9695747
35.
36.

Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis.

Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP.

Fertil Steril. 1998 Jun;69(6):1042-7.

PMID:
9627290
37.

Cytolytic activity of peripheral blood blast cells from patients with acute myeloid leukemia.

Braun DP, Preisler HD.

Leuk Lymphoma. 1997 Nov;27(5-6):459-67.

PMID:
9477127
38.

Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6.

Ahn MC, Siziopikou KP, Plate JM, Casey L, Silver M, Harris JE, Braun DP.

Cancer Immunol Immunother. 1997 Oct;45(1):37-44.

PMID:
9353425
39.

Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes.

Siziopikou KP, Ahn MC, Casey L, Silver M, Harris JE, Braun DP.

Cancer Immunol Immunother. 1997 Oct;45(1):29-36.

PMID:
9353424
40.

Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis.

Braun DP, Gebel H, House R, Rana N, Dmowski NP.

Fertil Steril. 1996 Jun;65(6):1125-9.

PMID:
8641484
41.

Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis.

Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP.

Fertil Steril. 1996 May;65(5):925-30.

PMID:
8612850
42.

Differential expression of VLA beta 1 (CD29) on monocytes from patients with endometriosis.

Gebel HM, Rana N, Braun DP, Dmowski WP.

Am J Reprod Immunol. 1995 Nov;34(5):317-22.

PMID:
8595131
43.
44.

Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis.

Braun DP, Muriana A, Gebel H, Rotman C, Rana N, Dmowski WP.

Fertil Steril. 1994 Jan;61(1):78-84.

PMID:
8293848
45.

The role of cell-mediated immunity in pathogenesis of endometriosis.

Dmowski WP, Gebel HM, Braun DP.

Acta Obstet Gynecol Scand Suppl. 1994;159:7-14. Review.

PMID:
8209672
46.

Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism.

Braun DP, Ahn MC, Harris JE, Chu E, Casey L, Wilbanks G, Siziopikou KP.

Cancer Res. 1993 Jul 15;53(14):3362-8.

47.

Mitogen induced production of polyclonal IgG is decreased in women with severe endometriosis.

Gebel HM, Braun DP, Rotman C, Rana N, Dmowski WP.

Am J Reprod Immunol. 1993 Mar;29(2):124-30.

PMID:
8329105
49.

The development of cytotoxicity in peritoneal macrophages from women with endometriosis.

Braun DP, Gebel H, Rotman C, Rana N, Dmowski WP.

Fertil Steril. 1992 Jun;57(6):1203-10.

PMID:
1601140
50.

Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer.

Siziopikou KP, Harris JE, Casey L, Nawas Y, Braun DP.

Cancer. 1991 Sep 1;68(5):1035-44.

PMID:
1655212

Supplemental Content

Loading ...
Support Center